Realistic expectations: trial data shows semaglutide patients losing about 15% of body weight and tirzepatide patients 20%+ — over a year or more, with full dose titration and lifestyle support. Early months are slower as doses ramp up. Anyone promising dramatic monthly numbers is selling something. Our program builds the medication into a sustainable plan with monthly monitoring.